Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.
about
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathwayIdentification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virionsEfficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signalIdentification of APOBEC3DE as another antiretroviral factor from the human APOBEC familyRole of the karyopherin pathway in human immunodeficiency virus type 1 nuclear importMutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 VprA synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibitionHuman immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cellsPyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activityMultiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication.Human immunodeficiency virus type 1 cDNA integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism.Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.Interaction of Moloney murine leukemia virus matrix protein with IQGAPA molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusionAdvanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell lineProduction of high-titer helper-free retroviruses by transient transfectionStructural and sequencing analysis of local target DNA recognition by MLV integrase.HIV-1 infection of T cells and macrophages are differentially modulated by virion-associated Hck: a Nef-dependent phenomenonHuman Polycomb group EED protein negatively affects HIV-1 assembly and release.Moloney leukemia virus immortalizes B lymphocytes in vitroMutational analysis of the gag-pol junction of Moloney murine leukemia virus: requirements for expression of the gag-pol fusion protein.Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteinsDomain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.The alpha and beta chains of avian retrovirus reverse transcriptase independently expressed in Escherichia coli: characterization of enzymatic activities.Infection of rabbit T-cell and macrophage lines with human immunodeficiency virus.Effects of 3' untranslated region mutations on plus-strand priming during moloney murine leukemia virus replication.Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host rangesXenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells.The proteolytic cleavage of human immunodeficiency virus type 1 Nef does not correlate with its ability to stimulate virion infectivity.In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G proteinSynergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins.Role of variable regions A and B in receptor binding domain of amphotropic murine leukemia virus envelope protein.Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replicationReplication defect of moloney murine leukemia virus with a mutant reverse transcriptase that can incorporate ribonucleotides and deoxyribonucleotides.Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses.A novel subgenomic murine leukemia virus RNA transcript results from alternative splicing.Suppression of a fusion defect by second site mutations in the ecotropic murine leukemia virus surface protein.The gag domains required for avian retroviral RNA encapsidation determined by using two independent assays.Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus.Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties
P2860
Q24642513-E845C4E0-CA06-45A5-96FE-7EF06048F866Q24645417-C7A89F0C-5652-49BD-9854-6F37A1C9DE70Q24645635-A1053138-D0F8-4BBC-9089-AAB6AEA1AA35Q24670173-53568325-0046-4C38-A75F-FC541EEA15A5Q24684268-3DA3355C-024B-4F11-85FA-A4F90B39EB59Q24684633-8ACDA873-B8A5-4A59-AE0E-2C3505F505DFQ28317348-66EF87DA-C6F6-493A-AD9F-A4566D8E7DCAQ28318483-131A9719-B6E7-4295-89D7-15D44387DF9CQ28323976-B85B47CE-82F0-4AFE-A168-F0A397BA7A0FQ28343701-5B056062-67E4-4DB7-BD50-BC488083A783Q28368861-86F8EA9B-F9A6-49B5-AC54-21FAA7D44C8BQ28379310-E45F99D8-7E17-48D9-866A-A447CBC6EEF4Q28589348-582FA959-CA0D-4CDC-9410-7DDEB32F9062Q28646828-C772AEDB-FD4E-4850-98F0-1BD1C9283065Q29547239-8A80B8EC-D571-4AB4-8D75-7D5F4BBBD5ECQ29547802-91698BAB-886F-475C-B0E6-04E530A9C37FQ30009173-07ACF0F4-67E0-4869-8D80-B524261FF4D8Q30009553-23536F42-C51A-4557-876D-3D2A37939597Q30444754-8E305B39-E5EF-4A50-A479-841B040EA614Q30452173-52BE8263-61EB-45DC-B6F6-98C36FEB8B28Q33191259-FE94ACC4-706A-43D9-9234-A1F43241B029Q33257614-DB2136B2-811C-487A-85B6-4A0DBCE44FB6Q33559415-6BB1075A-B24E-4317-BE08-20EA29862950Q33573277-DCC71D4A-4078-44E8-AB91-21FC418F9018Q33582527-59D93AF4-B116-4EAE-8F12-F9CA4B0D83C8Q33640102-4EB7DE36-CDD7-48B7-96AC-E785872E04F8Q33644899-BD91DF4D-1C0C-482A-ACBC-F54303A16FE2Q33648964-99622BB4-9F4F-4563-8728-3FDE8B6A2664Q33783315-E79FFC28-1EA4-4F06-8482-C073AAA39BD7Q33783325-52B37A8D-F72C-4483-A28B-EB19FA411720Q33783353-7C826A82-7212-4ABC-93B3-3FB1F7033545Q33785388-AD329927-F68F-4522-B5E6-6729B944BB37Q33785650-85E42DF9-A17B-44B1-AE31-62A36EC36F2EQ33785668-369E6A15-197C-4ADE-8167-42BC0C0BFD0EQ33796518-673C2ADE-9F3F-4DE8-A539-55EA2B0C7954Q33802491-1D3A0B2C-5C74-4230-9CAF-905BF8B988CAQ33814294-B3E15950-0024-48E3-9CD0-3B4B1BD45EF8Q33816490-39FE027C-EF54-41C2-8FE4-B1F03959B210Q33822095-E678B3C2-32FE-4B8E-8878-216AB2D9B9C4Q33825632-A9176EE1-EB4F-49EE-AD5A-311A78F4CB48
P2860
Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.
description
1981 nî lūn-bûn
@nan
1981 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Isolation and properties of Mo ...... virion reverse transcriptase.
@ast
Isolation and properties of Mo ...... virion reverse transcriptase.
@en
type
label
Isolation and properties of Mo ...... virion reverse transcriptase.
@ast
Isolation and properties of Mo ...... virion reverse transcriptase.
@en
prefLabel
Isolation and properties of Mo ...... virion reverse transcriptase.
@ast
Isolation and properties of Mo ...... virion reverse transcriptase.
@en
P2093
P2860
P1433
P1476
Isolation and properties of Mo ...... virion reverse transcriptase.
@en
P2093
P2860
P304
P407
P577
1981-04-01T00:00:00Z